Along with MHC class I (MHCI), 2B4 provides nonredundant NK-cell inhibition in mice.The immunoregulatory role of 2B4 has been increasingly appreciated in models of tumor and viral infection, however, the interactions among 2B4, MHCI, and other activating NK-cell receptors remain uncertain. Here, we dissect the influence of two distinct inhibitory pathways in modulating NK-cell-mediated control of tumors expressing strong activating ligands, including RAE-1γ. In vitro cytotoxicity and in vivo peritoneal clearance assays using MHCI + CD48 + (RMA-neo), MHCI + CD48 + RAE-1γ (RMA-RAE-1γ), MHCI − CD48 + (RMA-S-neo), and MHCI − CD48 + RAE-1γ (RMA-S-RAE-1γ) tumor lines demonstrated that NKG2D activation supersedes the inhibitory effect of both 2B4-and MHCI-mediated immune-tolerance systems. Furthermore, 2B4KO mice subcutaneously challenged with RMA-neo and RMA-S-neo exhibited reduced tumor growth and significantly prolonged survival compared with WT mice, implying that 2B4 is constitutively engaged in the NK-cell tolerance mechanism in vivo. Nevertheless, the inhibitory effect of 2B4 is significantly attenuated when NK cells encountered highly stressed tumor cells expressing RAE-1γ, resulting in an immune response shift toward NK-cell activation and tumor regression. Therefore, our data highlight the importance of the 2B4-mediated inhibitory system as an alternate self-tolerance mechanism, whose role can be modulated by the strength of activating receptor signaling within the tumor microenvironment.Keywords: 2B4 r Natural killer cells r NKG2D r self-tolerance Additional supporting information may be found in the online version of this article at the publisher's web-site Recent work has revealed the existence of an alternate NK-cell inhibitory system, independent of MHCI molecules, which provides an added level of self-tolerance [6]. Of the non-MHC binding receptors, 2B4 (CD244) is ubiquitously expressed on all NK cells [7,8] and provides inhibition against CD48-expressing hematopoietic and tumor cells [9]. 2B4 is a member of signaling lymphocyte activation molecule (SLAM) receptor family that has been shown to exert both activating and inhibitory roles in NK cells [10]. In mature human NK cells, 2B4 functions primarily as an activating and costimulatory receptor, but it can also act as an inhibitory receptor in developing NK cells to ensure self-tolerance against neighboring hematopoietic compartments [11]. By contrast, the major role of 2B4 in murine NK cells has been shown to be inhibitory both in vitro and in vivo [6,9,12]. 2B4-deficient mice demonstrate enhanced killing of CD48 + tumor cells by 2B4KO NK cells over that by wild-type NK cells [9] and more efficient regression of tumors in vivo [13], suggesting that murine 2B4 functions as an inhibitory receptor. In addition, 2B4 inhibits NK-cell production of IFN-γ in recognition of CD48 + tumor targets. These data demonstrate that the mouse 2B4/CD48 pair provides an important MHCI-independent inhibitory system for NK-cell self-tolerance. We have shown previously that...